Showing results (451-460 of 514) with videos related to
Sort By:
Pageof 52
The Journal of Cell Biology|April 15, 2015
TMEM231, mutated in orofaciodigital and Meckel syndromes, organizes the ciliary transition zoneElle C Roberson, William E Dowdle, Aysegul Ozanturk, et al.Journal of Psychiatry & Neuroscience : JPN|April 3, 2019
Randomized controlled trial of a gluten-free diet in patients with schizophrenia positive for antigliadin antibodies (AGA IgG): a pilot feasibility studyDeanna L. Kelly, Haley K. Demyanovich, Katrina M. Rodriguez, et al.Age and Ageing|March 23, 2024
The Conceptual Definition of Sarcopenia: Delphi Consensus from the Global Leadership Initiative in Sarcopenia (GLIS)Ben Kirk, Peggy M Cawthon, Hidenori Arai, et al.Journal of Medical Genetics|February 11, 2016
Genetic spectrum of Saudi Arabian patients with antenatal cystic kidney disease and ciliopathy phenotypes using a targeted renal gene panelMohamed H Al-Hamed, Wesam Kurdi, Nada Alsahan, et al.Kidney International|October 22, 2015
Whole exome sequencing identifies causative mutations in the majority of consanguineous or familial cases with childhood-onset increased renal echogenicityDaniela A Braun, Markus Schueler, Jan Halbritter, et al.Kidney International|July 8, 2020
Clinical spectrum, prognosis and estimated prevalence of DNAJB11-kidney diseaseVinh T Huynh, Marie-Pierre Audrézet, John A Sayer, et al.BMJ Medicine|February 27, 2026
Making clinical guidelines work for people with multiple long term conditions: analysis and recommendations from review of single condition guidelinesSara Pretorius, Victoria Bartle, Sue Bellass, et al.American Journal of Human Genetics|July 27, 2022
Monoallelic pathogenic ALG5 variants cause atypical polycystic kidney disease and interstitial fibrosisHugo Lemoine, Loann Raud, François Foulquier, et al.Journal of Cachexia, Sarcopenia and Muscle|December 4, 2021
Epigenome-wide association study of sarcopenia: findings from the Hertfordshire Sarcopenia Study (HSS)Elie Antoun, Emma S Garratt, Andrea Taddei, et al.Proceedings of the National Academy of Sciences of the United States of America|August 10, 2022
An intermediate-effect size variant in UMOD confers risk for chronic kidney diseaseEric Olinger, Céline Schaeffer, Kendrah Kidd, et al.Pageof 52